Contrasting Sernova (OTCMKTS:SEOVF) & LifeVantage (OTCMKTS:LFVN)

Share on StockTwits

Sernova (OTCMKTS:SEOVF) and LifeVantage (NASDAQ:LFVN) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, risk, valuation and analyst recommendations.

Insider and Institutional Ownership

41.0% of LifeVantage shares are owned by institutional investors. 3.9% of LifeVantage shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Analyst Ratings

This is a breakdown of current recommendations for Sernova and LifeVantage, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sernova 0 0 0 0 N/A
LifeVantage 0 0 0 0 N/A

Profitability

This table compares Sernova and LifeVantage’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Sernova N/A -106.93% -93.65%
LifeVantage 3.29% 36.85% 16.51%

Risk & Volatility

Sernova has a beta of 1.08, suggesting that its share price is 8% more volatile than the S&P 500. Comparatively, LifeVantage has a beta of 0.67, suggesting that its share price is 33% less volatile than the S&P 500.

Valuation & Earnings

This table compares Sernova and LifeVantage’s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Sernova N/A N/A -$2.87 million N/A N/A
LifeVantage $225.96 million 0.86 $7.43 million $0.59 23.20

LifeVantage has higher revenue and earnings than Sernova.

Summary

LifeVantage beats Sernova on 7 of the 8 factors compared between the two stocks.

Sernova Company Profile

Sernova Corp., a clinical-stage regenerative medicine therapeutics company, focuses on the development and commercializing of its proprietary Cell Pouch and associated technologies, including therapeutic cells and local immune protection. The company is developing a Cell Pouch system that is in Phase I/II clinical trial for the treatment of type-1 diabetes. Its Cell Pouch system is a medical device designed to create a vascularized tissue environment for the transplantation and engraftment of therapeutic cells for the treatment of chronic diseases, such as hemophilia A and thyroid diseases. Sernova Corp. is headquartered in London, Canada.

LifeVantage Company Profile

LifeVantage Corporation engages in the identification, research, development, and distribution of nutraceutical dietary supplements and skin care products. The company offers Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skin care product; Axio, a line of energy drink mixes; Omega+, a fish oil dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and Vitamin D3; and PhysIQ, a weight management system, as well as Petandim for Dogs, a companion pet supplement formulated to treat oxidative stress in dogs. It also provides skin care products, including facial cleansers, perfecting lotions, eye serums, anti-aging creams, hand creams, and micro-lift serums; and Hair Care System under the TrueScience brand name. The company sells its products through a direct sales model, as well as a network of independent distributors in the United States, Japan, Hong Kong, Australia, Canada, Mexico, Thailand, the United Kingdom, the Netherlands, Germany, Spain, and Taiwan. LifeVantage Corporation is headquartered in Sandy, Utah.

Receive News & Ratings for Sernova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sernova and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Peel Hunt Reaffirms “Buy” Rating for CLS
Peel Hunt Reaffirms “Buy” Rating for CLS
Contrasting Sernova  & LifeVantage
Contrasting Sernova & LifeVantage
Head-To-Head Review: Vonovia SE Depository Receipt  vs. Government Properties Income Trust
Head-To-Head Review: Vonovia SE Depository Receipt vs. Government Properties Income Trust
Head to Head Survey: BeyondAirInc   .  & Its Competitors
Head to Head Survey: BeyondAirInc . & Its Competitors
Palomar  vs. Heritage Insurance  Financial Contrast
Palomar vs. Heritage Insurance Financial Contrast
Berenberg Bank Reiterates “€39.00” Price Target for Deutsche Wohnen
Berenberg Bank Reiterates “€39.00” Price Target for Deutsche Wohnen


© 2006-2019 Ticker Report